ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 18 of 492 for:    Harvard

Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02752061
Recruitment Status : Recruiting
First Posted : April 26, 2016
Last Update Posted : August 29, 2017
Sponsor:
Collaborators:
Brigham and Women's Hospital
Botswana Harvard Aids Institute
Botswana Ministry of Health
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Scott Dryden-Peterson, Harvard School of Public Health

Brief Summary:

Diagnostic and treatment delays contribute substantially to disparities in cancer morbidity and mortality between low- and middle- income countries (LMICs) and high-income countries. Individuals present with advanced stage disease resulting in minimal chance for cure or long-term survival.

The Potlako project will implement and evaluate a multifaceted intervention to test the hypothesis that a package of enhanced coordination of care including an electronic messaging, transportation support, and training targeted at generalist clinicians at primary and secondary level facilities, can reduce time to diagnosis and stage at diagnosis for HIV-infected individuals with cancer.


Condition or disease Intervention/treatment Phase
Neoplasms HIV Healthcare Disparity Other: Potlako intervention Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 2600 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Potlako: A Programmatic Multi-facility Level Intervention to Improve Access to Timely Oncology Care in Botswana
Actual Study Start Date : April 2016
Estimated Primary Completion Date : April 2019
Estimated Study Completion Date : April 2019

Arm Intervention/treatment
Experimental: Kweneng East District
Patient presenting with possible cancer symptoms/sign to a clinic or hospital in Kweneng East District during study period.
Other: Potlako intervention

Multicomponent intervention including:

  • provider training on early detection and diagnostic approaches to cancer
  • patient education on importance of obtaining timely cancer diagnosis
  • provision of a patient navigator to facilitate diagnosis and entry into care
  • provision of transportation support to vulnerable patients

No Intervention: All other districts
Patient presenting with possible cancer symptoms/sign to a clinic or hospital in all other districts of Botswana (or Kweneng East prior to implementation of intervention).



Primary Outcome Measures :
  1. Cancer stage [ Time Frame: 1 day visit ]
  2. Time from initial clinic visit with cancer symptom/sign to entry into oncology care [ Time Frame: 1 day visit ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Citizen of Botswana
  • Suspected or diagnosed cancer

Exclusion Criteria:

  • Involuntary incarceration

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02752061


Locations
Botswana
Botswana Harvard AIDS Institute Recruiting
Gaborone, Botswana
Contact: Kerapetse Botebele, RN       kbotebele@bhp.org.bw   
Principal Investigator: Neo Tapela, MD         
Sponsors and Collaborators
Harvard School of Public Health
Brigham and Women's Hospital
Botswana Harvard Aids Institute
Botswana Ministry of Health
Dana-Farber Cancer Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Scott Dryden-Peterson, Assistant Professor, Research Affiliate, Harvard School of Public Health
ClinicalTrials.gov Identifier: NCT02752061     History of Changes
Other Study ID Numbers: BHP078
First Posted: April 26, 2016    Key Record Dates
Last Update Posted: August 29, 2017
Last Verified: August 2017